Uterine fibroid embolisation (UFE), also known as uterine artery embolisation (UAE), can be seen as a transformative option in gynaecological healthcare, particularly for women with symptomatic fibroids aged 35-50 who are premenopausal and have completed their childbearing years.
This minimally invasive procedure, performed by an interventional radiologist (IR), addresses symptoms associated with fibroids and adenomyosis, offering an alternative to traditional surgical interventions such as hysterectomy or myomectomy. The procedure has been available in WA to public patients on an ad hoc basis, and is now consistently available in the private system.
UFE involves blocking the blood flow to fibroids and adenomyosis-affected tissues by injecting embolic material into the uterine arteries. This procedure, performed through a pinhole incision in the groin or wrist, allows patients to remain awake, aided by sedation, analgesia and local anaesthesia.
Post-procedure care usually involves a brief hospitalisation, typically lasting one night to manage any discomfort or side effects. Central to UFE is the collaborative decision-making process between patients, healthcare providers, and specialists. Thorough consultations with both a gynaecologist and an IR ensure that patients are well-informed about their condition, treatment options, and the potential outcomes of UFE.
The advantages of UFE over surgery include its minimally invasive nature and preservation of the uterus. In addition, the effectiveness in reducing symptoms such as heavy menstrual bleeding and pelvic pain or pressure have been demonstrated as near-equivalent to myomectomy. UFE boasts minimal blood loss, outpatient convenience, shorter hospital stays, and faster return to normal activities, making it a favourable choice for many eligible candidates.
However, it is essential to acknowledge potential disadvantages, such as post-procedural pain and discharge.
Nevertheless, for many women within the specified age range and clinical profile, UFE represents a significant advancement for women experiencing symptoms associated with fibroids and adenomyosis, without the need for major surgery. By offering a minimally invasive, uterus-preserving alternative, UFE empowers women to reclaim their health and quality of life.
Key messages
- Uterine fibroid embolisation is a minimally invasive non-surgical treatment option for fibroids
- The procedure is performed by an interventional radiologist
- UFE can be effective at symptom management.
Author competing interests – nil